Bridgefront Capital’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-11,713
Closed -$1.52M – 866
2025
Q2
$1.52M Buy
11,713
+9,994
+581% +$1.21M 0.4% 40
2025
Q1
$205K Buy
+1,719
New +$213K 0.06% 514
2024
Q3
– Sell
-6,742
Closed -$914K – 741
2024
Q2
$914K Buy
+6,742
New +$917K 0.38% 58
2023
Q3
– Sell
-1,820
Closed -$205K – 646
2023
Q2
$205K Buy
+1,820
New +$192K 0.11% 381
2021
Q3
– Sell
-3,032
Closed -$364K – 699
2021
Q2
$364K Sell
3,032
-2,625
-46% -$300K 0.14% 280
2021
Q1
$595K Sell
5,657
-6,158
-52% -$624K 0.19% 169
2020
Q4
$1.2M Buy
+11,815
New +$1.11M 0.41% 32

Other funds holding XYL

Bridgefront Capital's XYL Position: Q3 2025 in Review

Bridgefront Capital sold out of Xylem (XYL) in Q3 2025, closing a stake of 11,713 shares — an estimated $1.52M sold.

Bridgefront Capital first reported a position in XYL in Q4 2020 and held it in 7 quarters. The position peaked at $1.52M in Q2 2025. 1,085 funds tracked by Wall St. Rank hold XYL as of Q3 2025.

  • Bridgefront Capital reported no remaining Xylem position as of Q3 2025 after selling out during the quarter.
  • Bridgefront Capital sold 11,713 Xylem shares in Q3 2025, an estimated $1.52M.
  • Bridgefront Capital first reported a position in Xylem in Q4 2020 and held it in 7 quarters.
  • Bridgefront Capital's Xylem position peaked at $1.52M in Q2 2025.
  • 1,085 funds tracked by Wall St. Rank held Xylem as of Q3 2025.

Based on Bridgefront Capital's 13F filing for Q3 2025, filed 14 Nov 2025.